|
Several novel medications have been approved by the U.S. Food and Drug Administration (FDA) for the treatment of psoriasis in the past 20 years. While these therapies have ushered in an era of improved disease control, patient-reported outcomes still suggest failure to meet treatment goals. These expert offers their insight.
|